In an emergency, call 000. Training complements but does not replace professional emergency response.
Infant CPR practice on a training manikin during an education and care first aid class

Peanut Allergy Tests in Babies: What the ADAPT Study Found

November 16, 2026
Anaphylaxis and allergy

One in three babies thought to have peanut allergy passed a supervised challenge. What does that really mean?

Why a positive allergy test is not always the full diagnosis, and why anaphylaxis must still be taken seriously.

By Britt Brennan, REACHAU | 16 November 2026

Infant CPR practice on a training manikin during an education and care first aid class
Quick answer: In a 2026 Australian study of the national ADAPT program, 271 of 778 selected infants (34.8%) with a past reaction and a positive peanut allergy test did not react during a supervised hospital food challenge, so their suspected peanut allergy label could be removed. The same challenges caused 61 episodes of anaphylaxis. A positive test is not the whole diagnosis, a food challenge must never be tried at home, and suspected anaphylaxis still needs adrenaline straight away and a call to 000.

Imagine being told that your baby may have a peanut allergy.

Perhaps you offered a little peanut butter when your baby started eating solids. There was redness around the mouth, maybe a few hives, and naturally you became concerned. You sought medical advice, tests followed and the results suggested peanut allergy.

Suddenly you are checking labels, talking to relatives, making plans for childcare and wondering how to keep your child safe. Food becomes something you have to think about every time somebody else is involved in caring for your baby.

Now imagine learning that your child can safely eat peanut after all.

Not because someone encouraged you to try it again at home, but because a specialist team conducted a careful, medically supervised food challenge.

That possibility is at the heart of important Australian research reported in November 2026.

Researchers evaluating the national ADAPT Peanut Oral Immunotherapy Program found that 271 of 778 selected infants who underwent a supervised threshold peanut challenge did not react. They could have a suspected peanut allergy label removed.

It is an extraordinary finding, but there is another number in the same study that deserves equal attention.

Sixty-one infants experienced anaphylaxis during those challenges.

This is why the research matters. It is not about dismissing peanut allergy. It is about understanding the difference between a positive test, a suspected diagnosis and a confirmed clinical allergy, while recognising the very real danger of anaphylaxis.

What the Australian research found

The research was led by Dr Timothy Brettig, Professor Kirsten Perrett and colleagues through the Murdoch Children's Research Institute and the National Allergy Centre of Excellence. It evaluated ADAPT, a standardised model of peanut allergy treatment offered through ten Australian public hospital sites.

Between April 2024 and October 2025, clinicians assessed 1,275 infants. Of these, 778 underwent a threshold oral food challenge, a medical test in which measured doses of peanut protein were given under clinical supervision. The infants had their first reaction before 12 months of age. By the time of the challenge, their median age was 13 months.

The numbers at a glance (778 threshold challenges)

  • 271 negative (34.8%). These infants tolerated the challenge without an allergic reaction.
  • 507 positive (65.2%). These infants reacted to peanut during the challenge.
  • 61 anaphylaxis (12% of positive challenges, 7.8% of all challenges). All were managed by the hospital teams.

The different denominators matter. A media summary that says 12% developed anaphylaxis is describing the proportion among positive challenges, not all the infants who were challenged.

Equally, the 35% negative-challenge figure describes a selected group of infants who underwent a particular hospital testing pathway. It does not mean 35% of all Australians diagnosed with peanut allergy are incorrectly diagnosed.

And a negative challenge does not necessarily prove the child was never allergic. Some children may have had an allergy that resolved, while others may have been sensitised without developing ongoing clinical allergy.

The researchers were able to establish that these infants tolerated peanut at the time of the challenge. They could not identify the full reason for every negative result.

That distinction is central to telling this story responsibly.

A positive test and a food allergy are not the same thing

Here is a question I would love more people to understand: what does a positive allergy test actually tell us?

Skin prick testing and blood tests for specific IgE antibodies measure evidence that the immune system recognises a substance. This is known as sensitisation.

Sensitisation is not the same as having symptoms when the substance is eaten.

A person may show evidence of sensitisation without having a clinical food allergy. That is one of the reasons allergy specialists interpret results alongside the person's actual history.

What happened during the original exposure? How quickly did symptoms begin? Was the food swallowed? Were there hives, vomiting, coughing, breathing problems or swelling? Was more than one food offered? Has that food been tolerated before or since?

Those details can change how the results are understood.

In the ADAPT study, the threshold challenge group had both a prior history consistent with a mild or moderate IgE-mediated peanut reaction in infancy and evidence of sensitisation. Yet more than a third had no reaction during the supervised challenge.

A positive blood or skin test is useful information. It is not, on its own, a severity rating or a complete clinical diagnosis.

The researchers also found that although higher test results were associated with a greater likelihood of reacting, the measurements did not reliably predict either the amount needed to trigger a reaction or how severe that reaction would be.

That is an important lesson for parents and first aiders.

You cannot look at an IgE number and confidently predict how dangerous somebody's next reaction will be.

Why early reactions can be hard to interpret

Anyone who has helped a baby learn to eat knows that mealtimes can be messy.

Food gets onto the face. Babies rub their eyes and mouths. Skin can become irritated. Some babies already have eczema. Rashes and hives can also be caused by allergic reactions.

When symptoms appear soon after peanut is introduced, parents are right to take the possibility of allergy seriously and seek advice.

But a symptom occurring near a meal does not always establish exactly what caused it or whether there is a continuing allergy.

That is why diagnosis involves more than a laboratory result.

I am not suggesting families should ignore symptoms, and the ADAPT findings do not support that. I am saying that uncertainty deserves careful specialist assessment rather than an automatic assumption that a lifelong allergy has been proven.

There is a difference between being appropriately cautious while waiting for medical advice and carrying an allergy label indefinitely without having it reviewed.

What happens during a supervised oral food challenge?

An oral food challenge is a structured clinical assessment.

A medical team gives a food in carefully measured amounts and observes for signs of an allergic reaction. Doses may be gradually increased according to an established protocol. There are clinical criteria for when the test should be stopped.

The team is equipped to manage reactions, including anaphylaxis. ASCIA advises that food challenges are supervised by an allergy specialist or an appropriately trained doctor, in a clinic that can treat anaphylaxis immediately.

The ADAPT threshold challenge used up to seven escalating doses of peanut protein, from 15 mg to 1,300 mg. The protocol also helped establish the amount of peanut that triggered symptoms in infants who reacted, which could guide the starting dose of oral immunotherapy.

Not every infant followed the same pathway. Infants with a history of more severe reactions could be assessed using a different, lower-dose escalation protocol.

The seven-dose challenge is not a home recipe. It was designed for a selected population and a supervised hospital environment.

The safety message I most want you to keep

A food challenge must never be recreated by a parent, childcare worker, relative or first aider to see whether a child is "still allergic". If an allergy diagnosis needs reviewing, speak with the treating clinician.

Why the anaphylaxis results matter

The 61 anaphylaxis episodes in the study cannot be brushed aside.

Anaphylaxis can develop rapidly and may be life-threatening. The ADAPT publication reported that these episodes were safely managed by the teams conducting the challenges.

That tells us something valuable about controlled specialist assessment, not about the safety of trying the same thing elsewhere.

It also explains why specialist clinicians need to consider whether the potential diagnostic benefit of a challenge outweighs the individual child's risk.

A supervised challenge can prevent unnecessary avoidance or treatment, but it carries real risks.

Both statements can be true.

The danger comes when a news headline about children "not really being allergic" gets separated from the clinical context.

We must not allow parents to conclude that a child with a previous reaction and a positive allergy test should simply be given peanut at home to find out what happens.

What does an allergy label mean for a family?

It is easy for someone outside the situation to say, "Just avoid peanuts."

But consider what that actually asks of a family.

It means checking ingredients, planning meals outside the home, explaining the situation to grandparents, organising childcare information, thinking about cross-contact and preparing for the possibility of an emergency.

For some families, it adds fear to everyday experiences that other people take for granted.

Where a child genuinely has a food allergy, management is essential. The inconvenience does not make the diagnosis less important.

But if a child can safely eat peanut, unnecessary avoidance creates a burden that need not continue.

A label can also persist in records. A diagnosis entered in infancy may follow a child into childcare and school unless reviewed and updated.

That is why the ability to remove an inaccurate or no-longer-applicable diagnosis matters. It is not just an academic exercise. It can change daily life.

We should also avoid describing every removed label as proof that the original medical decision was wrong. A previous reaction may have been genuine. Allergy status can change, and diagnostic uncertainty can sometimes only be resolved with additional specialist testing.

What the study tells us about oral immunotherapy

The ADAPT initiative was established to deliver a more consistent model of peanut oral immunotherapy for eligible infants through Australian public hospitals.

Oral immunotherapy, or OIT, involves carefully controlled exposure to measured amounts of peanut under specialist supervision, followed by ongoing treatment according to a medical protocol. In ADAPT, families give a measured daily dose at home, and the dose is only increased at hospital visits, usually every four weeks.

It is intended to change the body's response to the allergen. But treatment is not the same as a guaranteed cure, and reactions can occur during treatment. ASCIA's 2026 position paper is clear that OIT is not a cure, that it is not suitable for everyone, and that strict avoidance remains the standard of care in Australia. Even people who reach remission are still advised to carry an adrenaline device.

The evaluation found that 384 of 394 infants commencing OIT, or 97.5%, successfully started at a dose guided by their challenge results.

That is a result about starting treatment safely within the program.

It does not mean that 97.5% were cured, stopped having allergy or achieved long-term remission.

Those longer-term outcomes need separate assessment.

The original ADAPT program design includes up-dosing, about two years of treatment, an eight-week avoidance period, a further supervised challenge and at least 12 months of follow-up.

The program has defined eligibility criteria. It should not be confused with giving peanut to a baby at home after an allergy has been suspected or diagnosed.

What does this mean for feeding babies?

Australian guidance encourages introducing common food allergens, including peanut, in an age-appropriate way when an infant is developmentally ready for solids, generally around six months and not before four months.

Once peanut has been introduced and tolerated, regular ongoing consumption is recommended.

Texture matters. Whole peanuts are a choking hazard for young children. Peanut can be offered as suitably thinned smooth peanut butter mixed into an age-appropriate food.

However, guidance about introducing foods to babies who have not reacted is not the same as advice for a baby who has already had a suspected allergic reaction.

If a reaction has occurred, obtain medical advice about the next steps rather than conducting your own reintroduction challenge.

Parents do not need to choose between dismissing a possible reaction and assuming that a diagnosis can never change. There is a third path: proper clinical assessment.

The Western Australian connection

This national research included sites in Western Australia, including Perth Children's Hospital and Fiona Stanley Hospital.

For families in Perth and surrounding areas, this makes the findings particularly relevant.

For regional families, another question arises: how accessible is specialist assessment?

I deliver first aid training in places where a specialist appointment is not a short drive away. In regional Western Australia, attending a hospital clinic can involve significant travel, time away from work, accommodation and arrangements for other family members.

The ADAPT research and program reporting acknowledge that geography and parental concerns can affect participation.

A diagnostic method may be valuable, but we also need to consider whether families can access it.

This would be worth following as the national model develops.

The existence of a program at a WA hospital does not mean every child or adult with a peanut allergy is eligible. Families should discuss referral options with their GP or allergy specialist.

Childcare, schools and the importance of current plans

Consider what happens when a child begins childcare with a documented peanut allergy.

There may be a medical management plan, an ASCIA Action Plan, staff training and arrangements around food.

Now imagine the child's allergy status changes after a supervised hospital assessment.

The service needs clear communication and appropriate updated medical documentation. Staff should not change arrangements based solely on a casual conversation or an assumption that an old diagnosis no longer matters.

Equally, an old allergy label should not simply remain on file forever if the treating team has formally changed the diagnosis.

Accurate information helps everyone: parents, educators and the child.

A first aider's job is not to interpret a child's skin prick test or decide whether the medical diagnosis is justified.

Their job is to know the current arrangements, recognise anaphylaxis and respond.

We need systems that can handle both things: reliable emergency plans and timely updates when medical advice changes. Our guide to connecting plans, people and practice in childcare first aid looks at how services can keep those plans current.

A question for your team

If a parent told you at pick-up that their child "isn't allergic anymore", what would your service need to see before changing anything, and who would update the plan and tell every staff member?

The first aid lesson I do not want people to miss

There is something about this research that could easily be misunderstood, and it directly affects how we teach anaphylaxis.

A clinician considering whether a child truly has peanut allergy is answering a diagnostic question.

A first aider responding to breathing difficulty, collapse or other signs of anaphylaxis is answering an emergency question.

Those are not the same question.

ASCIA's 2026 acute management guidance and ANZCOR Guideline 9.2.7 set out the priorities when anaphylaxis is suspected:

  1. Give adrenaline straight away. Follow the person's ASCIA Action Plan and the instructions on their device.
  2. Lay the person flat. If breathing is difficult, let them sit with their legs outstretched. Hold a baby or young child flat, not upright.
  3. Do not let them stand or walk, even if they start to seem better.
  4. If they are unconscious and breathing, place them in the recovery position.
  5. Call 000 for an ambulance.
  6. If they have known asthma and an allergy and suddenly have trouble breathing, give adrenaline first, then their asthma reliever.
  7. If they become unresponsive and are not breathing normally, start CPR.

Do not delay adrenaline to debate whether the allergy label was accurate. Do not rely on antihistamines as treatment for anaphylaxis. An asthma reliever does not replace adrenaline when anaphylaxis is suspected. If there is uncertainty, call 000 for guidance.

This is the part of first aid that needs confidence.

We may not know everything about why a person is reacting. We do not need a definitive laboratory diagnosis before responding to an apparent life-threatening allergic emergency.

In my classes I focus heavily on why we do things, because when people understand the reasoning they are more likely to act rather than freeze. If you want to explore that further, read why hesitation is the biggest first aid mistake.

And with anaphylaxis, delay matters.

Two extremes we must avoid

The first extreme is reading this research and deciding food allergy is exaggerated.

It is not. Hundreds of the challenged infants reacted, and some experienced anaphylaxis.

The second extreme is assuming that any child with a positive allergy test must avoid that food for life without further review.

That is not supported either.

The evidence invites a more thoughtful position.

  • Take suspected allergic reactions seriously.
  • Use qualified clinicians to interpret tests and make diagnoses.
  • Consider specialist food challenge when appropriate.
  • Keep management plans up to date.
  • Respond to suspected anaphylaxis without delay.

There is no contradiction in those instructions.

What we still need to learn

Several questions remain open.

  • How many of the infants with a negative challenge will continue to tolerate peanut over time?
  • How many originally had true allergy that resolved, and how many were sensitised without clinical allergy?
  • Would the same proportion tolerate peanut in an older group of children or a different clinical population? We cannot assume so.
  • What does the best follow-up process look like for families after a negative food challenge?
  • How do we make specialist assessment more accessible for regional Australian families?
  • Can the approach be adapted to other food allergies, and what would the risk-benefit balance be?

These are good questions for future research. They are not questions this study already answered.

Questions to ask your child's clinician

Parents who are uncertain about their child's peanut allergy diagnosis can ask:

  • What clinical history and test results support the diagnosis?
  • Is there a difference between sensitisation and confirmed allergy in my child's case?
  • Would a supervised oral food challenge be appropriate?
  • What are the risks, and what is the alternative if a challenge is not appropriate?
  • Is oral immunotherapy relevant to our circumstances?
  • What should we do while waiting for specialist assessment?
  • What action plan should childcare or school have?
  • If a supervised challenge is negative, what guidance will we receive for ongoing peanut consumption and updating records?

The point is to make informed decisions with a clinician, not to conduct home testing. If you suspect your baby has a peanut allergy, the first step is your GP, who can refer you to a paediatric allergy specialist.

Why this research matters to me

I love the moments during first aid training when people stop memorising steps and start understanding what they mean.

This study is full of those moments.

A positive test is not the same as a confirmed clinical allergy.

A negative supervised challenge can make a genuine difference to a family's life.

A challenge is not harmless just because it happens in a hospital. The risk is exactly why it needs trained clinicians and the right equipment.

And when someone is experiencing anaphylaxis, we do not wait for a discussion about diagnostic certainty.

For me, those lessons belong together.

We should never dismiss a serious allergic reaction. We should never encourage unsupervised food challenges. But we should also be willing to review a diagnosis when clinical evidence suggests it may not reflect the person's current situation.

That is how we make care more accurate without making it less safe.

The bottom line

The Australian ADAPT study found that 271 of 778 selected infants with a previous reaction history and evidence of peanut sensitisation did not react during a supervised threshold challenge.

Their suspected peanut allergy labels could be removed under specialist care.

The same study also recorded 61 episodes of anaphylaxis during testing.

Both findings are important.

One tells us that diagnosis can sometimes be less certain than families realise, and that specialist assessment can prevent unnecessary restriction and treatment.

The other tells us why a food challenge is never something to improvise at home.

When a child has a suspected allergy, seek appropriate medical assessment.

When a person develops anaphylaxis, respond to the emergency in front of you.

Understanding the difference is part of keeping people safe.

Frequently asked questions

Did the ADAPT study show that a third of peanut allergy diagnoses are wrong?

No. 271 of 778 selected infants (34.8%) did not react during a supervised challenge. They were a specific group who had a past reaction and a positive test, so the figure cannot be applied to everyone diagnosed with peanut allergy.

Does a positive skin prick or blood test mean my baby has a peanut allergy?

Not on its own. A positive test shows sensitisation, meaning the immune system recognises peanut. A specialist diagnoses allergy by combining test results with the history of what happened, and sometimes a supervised food challenge.

Can I test whether my child has outgrown a peanut allergy at home?

No. In the ADAPT study, 61 infants had anaphylaxis during hospital challenges. Food challenges should only happen under specialist supervision with emergency treatment on hand. Talk to your GP or allergy specialist.

Is oral immunotherapy a cure for peanut allergy?

No. ASCIA says OIT is not a cure. It can reduce sensitivity while doses continue, reactions can happen during treatment, and strict avoidance is still the standard of care in Australia.

What should I do if a child shows signs of anaphylaxis?

Give adrenaline straight away, lay them flat (or let them sit with legs outstretched if breathing is hard), do not let them stand or walk, and call 000. Do not wait to question whether their allergy diagnosis is accurate.

When should babies be introduced to peanut?

Australian guidance is to introduce peanut, in a safe form such as thinned smooth peanut butter, when your baby is ready for solids, around six months and not before four months, then keep giving it regularly. If your baby has already reacted, get medical advice first.

Sources and current guidance

Test how you would respond. Take the free 8-question quiz and get the Anaphylaxis Action Pack.

Learn the skills. Build the confidence. Be ready to help.

REACHAU first aid training focuses on understanding what to do, why it matters and how to act when someone needs help. Educators and carers can train in HLTAID012 Provide First Aid in an education and care setting, which includes anaphylaxis and asthma management for children.

View upcoming first aid sessions

Training and Assessment is delivered by Britt at Regional Education and Career Help Australia on behalf of ABC First Aid RTO 3399.

Support anaphylaxis awareness

REACHAU is fundraising to support allergy and anaphylaxis awareness. Donate to our fundraising page.

Related reading

This article is general education, not individual medical advice, and it does not replace an action plan from a doctor or hands-on training. Follow current ASCIA guidance and the person's individual medical management plan. Never attempt a food challenge at home. In an emergency in Australia, call 000.

Britt Brennan

Britt Brennan

Britt Brennan is an Empowerment-Focused First Aid Trainer and Employment Coach, with a Bachelor of Health Science and a Diploma of Mental Health. Through REACHAU, Britt delivers practical first aid training across Perth and regional Western Australia. Her teaching focuses on understanding why first aid techniques work, practising the skills and building the confidence to use them in a real emergency. Britt believes there is a big difference between being certified and being capable. Her goal is for every participant to leave knowing they can make a difference when someone needs help.

LinkedIn logo icon
Instagram logo icon
Youtube logo icon
Back to Blog